Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that recruitment for this study has ended. The study history also shows a new revision label v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.4%

- Check20 days agoChange DetectedA new revision label v3.5.5 appears in the history, and the previous v3.5.4 entry is removed, reflecting an update to the page's revision history.SummaryDifference0.1%

- Check34 days agoChange DetectedA new revision entry, v3.5.4, was added to the study record history. This indicates an update to the record that supersedes the previous v3.5.3 revision.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.5.3 was added to the page, replacing the previous v3.5.2. This represents a small update to the page's version labeling in the Record History.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.0 to v3.5.2. This does not indicate any change to the underlying study information.SummaryDifference0.1%

- Check92 days agoChange DetectedThe history section shows Revision: v3.5.0 as the latest entry, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.